Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Overman, M.D.
Children's Hospitals and Clinics of Minnesota
Principal Investigator - Harold M Burkhart, M.D.
Oklahoma University Children's Hospital
Principal Investigator - James Jaggers, M.D.
Children's Hospital Colorado
Principal Investigator - Joseph W Rossano, M.D.
Children's Hospital of Philadelphia
Principal Investigator - Muhammad Y Qureshi, MBBS
Mayo Clinic
Principal Investigator - Ram Kumar Subramanyan, M.D., Ph.D.
Children's Hospital Los Angeles
Principal Investigator - Timothy J Nelson, M.D., Ph.D.
Mayo Clinic
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S Hospital of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Oklahoma University Children'S Hospital
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 May 2013
- Primary completion
- 28 Apr 2021
- Completion
- 28 Apr 2021
- Last update posted
- 29 Apr 2022
- Registered enrollment
- 30
- Registry id
- NCT01883076
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.